Tirzepatide product presentation

PRODUCT DATA SHEET

Tirzepatide

Lyophilized powder. White to off-white lyophilized powder. Review the catalog presentations below and request current availability and lot documentation.

Packaging10 sealed vials per kit
Intended useLaboratory research use only
Catalog codePresentation
TR1010 mg x 10 vials
TR1515 mg x 10 vials
TR2020 mg x 10 vials
TR3030 mg x 10 vials
TR4040 mg x 10 vials
TR6060 mg x 10 vials
Ask about this product on WhatsApp ↗

PRODUCT INFORMATION

Identity and presentation.

Form
Lyophilized powder
Appearance
White to off-white lyophilized powder.
CAS No.
2023788-19-2
Sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(AEEA-AEEA-gamma-Glu-eicosanedioic acid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
Packaging
10 sealed vials per kit
Intended use
Laboratory research use only

COA & TESTING

Lot documentation.

  • Lot-specific Certificate of Analysis available for each production lot.
  • HPLC analysis documents purity and chromatographic profile.
  • Mass spectrometry may be used to confirm compound identity.
  • Final test results are reported in the COA supplied with the lot.

STORAGE & HANDLING

Material handling.

Lyophilized material

Store at -20°C in a tightly sealed vial, protected from light and moisture. Allow the sealed vial to reach room temperature before opening.

After reconstitution

For short-term laboratory handling, keep at 2-8°C. For longer storage, aliquot and freeze at <=-20°C when the experimental buffer is compatible. Avoid repeated freeze-thaw cycles.

INDEPENDENT TESTING

Browse our public report library.

View test reports
WhatsApp